RTRichard J. Traystman

Richard J. Traystman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Richard J. Traystman has a total of 106 co-authors. Here are the top co-authors by number of shared publications:

  • Patricia D. Hurn

    Department of Anesthesiology and Perioperative Medicine, UHS-2 3181 SW Sam Jackson Park Rd., Portland, OR 97239-3098, United States

    7 shared publications
  • Julia Kofler

    Department of Anesthesiology and Peri-Operative Medicine, Oregon Health and Science University, Portland, Oregon, USA

    6 shared publications
  • Marjorie R Grafe

    Department of Anesthesiology and Peri-Operative Medicine, Oregon Health and Science University, Portland, Oregon, USA

    4 shared publications
  • Paco S. Herson

    Department of Anesthesiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmacology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA

    3 shared publications
  • Paco S. Herson

    Department of Neurological Surgery, The Ohio State University, Columbus, OH, USA

    3 shared publications
  • Ruediger Noppens

    3 shared publications

Latest Publications

  • Endogenous Sex Steroids Dampen Neuroinflammation and Improve Outcome of Traumatic Brain Injury in Mice

    by Amy C. Clevenger, Hoon Kim, Ernesto Salcedo, Joan C. Yonchek, Krista M. Rodgers, James E. Orfila, Robert M. Dietz, Nidia Quillinan, Richard J. Traystman, Paco S. Herson

    The role of biological sex in short-term and long-term outcome after traumatic brain injury (TBI) remains controversial. The observation that exogenous female sex steroids (progesterone and estrogen) reduce brain injury coupled with a small number of clinical studies showing smaller injury in women suggest that sex steroids may play a role in outcome from TBI. We used the controlled cortical impact (CCI) model of TBI in mice to test the hypothesis that after CCI, female mice would demonstrate less injury than male mice, related to the protective role of endogenous steroids. Indeed, adult females exhibit histological protection (3.7 ± 0.5 mm3) compared to adult male mice (6.8 ± 0.6 mm3), and females that lacked sex steroids (ovex) showed increased injury compared to intact females. Consistent with histology, sensorimotor deficits measured as reduced contralateral limb use were most pronounced in male mice (31.9 ± 6.9% reduced limb use) compared to a 12.7 ± 3.8% reduction in female mice. Ovex mice exhibited behavioral deficits similar to males (31.5 ± 3.9% reduced limb use). Ovex females demonstrated increased microglial activation relative to intact females in both the peri-injury cortex and the reticular thalamic nucleus. Ovex females also demonstrated increased astrogliosis in comparison to both females and males in the peri-injury cortex. These data indicate that female sex steroids reduce brain sensitivity to TBI and that reduced acute neuroinflammation may contribute to the relative protection observed in females.


  • Abstract WP95: Cortical Neurogenesis in the Juvenile Brain Following Ischemic Stroke

    by Krista M Rodgers, Olivia P Patsos, Joan C Yonchek, Richard J Traystman, Wendy B Macklin, Paco S Herson

    Introduction: Ischemic stroke is a common injury of the CNS, resulting in neuronal death and impaired brain function, likely contributing to long-term disability in adults. The lack of pharmacological interventions for patients with impairments in stroked-injured brain regions signals need for new strategies aimed at restoring function to the post-ischemic brain. Neurogenesis involves the generation of newborn neurons and occurs throughout life in the mammalian brain, making it an appealing target for potential interventions to enhance post-stroke recovery. Stroke-induced neurogenesis in adult mice has been reported to involve vigorous proliferation and migration of neural progenitors, but most cells die rapidly and fail to repopulate damaged areas. We tested the hypothesis that cortical neurogenesis is enhanced in the immature brain. Methods: We compared juvenile (P20-25) and adult (P60) mice following 45min transient middle cerebral artery occlusion (MCAo). Neurogenesis was examined with immunohistochemistry, including bromodeoxyuridine (BrdU) labeling and cell-type specific markers at 24hr, 7d, and 30d. Post-ischemic neurobehavioral outcomes were assessed at baseline, 7d, and 30d. Results and Conclusions: Despite extensive neuronal cell death in the injured cortex of both age groups at acute time points (24hr and 7d), a remarkable regenerative response was found at 30d, with substantially more mature newborn neurons found in juveniles than adults. Behavioral tests revealed reductions in affected limb use and general motor functioning in MCAo-injured adults and juveniles at 7d, with only the juveniles returning to near baseline levels on most tasks by 30d. When neurogenesis was arrested with ionizing radiation, 30d behavioral recovery was lost. Evidence of cortical neurogenesis is scarce; however, we discovered that newborn neurons in the developing brain not only survive, but post-stroke behavioral outcomes are only improved in non-irradiated juvenile mice. These results provide support for cortical neurogenesis, neuronal replacement, and enhanced functional recovery following stroke, which may have major biological significance for endogenous recovery and repair following CNS damage.

  • Abstract WP253: CaMKII Inhibition Protects Against Purkinje Cell Damage Following Global Cerebral Ischemia

    by Olivia Patsos, Nicholas Chalmers, Katie Steklac, Richard J Traystman, Paco S Herson, Nidia Quillinan

    Introduction: Ischemic damage triggers glutamate excitotoxicity, resulting in neuronal cell death. Previous research has demonstrated that NMDA receptor activity triggers downstream calcium-dependent signaling pathways, specifically Ca2+/calmodulin-dependent protein kinase II (CaMKII). We hypothesize that Death Associated Protein Kinase I (DAPKI) and receptor interacting protein (RIP) are downstream of CaMKII, contributing to necroptosis. Focal and global ischemia studies have shown that inhibiting CaMKII is protective against hippocampal damage, but there is little known about cerebellar cell death mechanisms. The aim of this study is to examine the neuroprotective potential of inhibiting CaMKII in Purkinje cells using a global ischemia model. Methods: C57BL/6 male adult mice were subjected to 8 minutes of cardiac arrest and cardiopulmonary resuscitation (CA/CPR). Mice were randomized to tat-CN19o or control peptide (tat-SCR), administered 30 minutes after CA/CPR, and cerebellar injury analyzed 7 days after CA/CPR. Western blot analysis of cerebellar homogenates performed 6 hrs after CA/CPR. Phosphorylated and total CAMKII, DAPKI, and total RIP was quantified. Statistical analyses were performed using 1-WAY ANOVA, with PResults: Analysis of Purkinje cell death revealed injury at 7 days after CA/CPR that was prevented with tat-CN19o at doses of 0.1 and 1 mg/kg. We observed an increase in T286-P of CAMKII at 6 hours after CA/CPR, concurrent with increased DAPK1 activity (reduced phosphorylation) and increased RIP expression. Administration of tat-CN19o prevented CA/CPR-induced changes in DAPK1 and RIP, while having no effect on CAMKII. Conclusions: Autonomous activity of CAMKII is increased by ischemia in the cerebellum, which contributes to cell death. Neuroprotection with tat-CN19o occurred at doses 10-fold higher than that needed for protection in the hippocampus (Deng, Cell Reports, 2017). Importantly, we have identified signaling pathways downstream of CAMKII that may contribute to Purkinje cell death, DAPK1 and RIP. In summary, our findings indicate that inhibition of autonomous CaMKII activity is a promising therapeutic approach.

  • The Clinical Significance of Collateral Ventilation

    by Peter B. Terry, Richard J. Traystman

    Oxygen delivery and carbon dioxide removal being critical to cell survival, mammals have developed collateral vascular and ventilation systems to ensure tissue viability. Collateral ventilation, defined as ventilation of alveoli via pathways that bypass normal airways, is present in humans and many other species. The presence of collateral ventilation can be beneficial in certain disease states, whereas its relative absence can predispose to other diseases. These well defined anatomical pathways contribute little to ventilation in normal humans, but modulate ventilation perfusion imbalance in a variety of diseases, including obstructive diseases, such as asthma and emphysema. These pathways can be affected by pharmaceuticals and inhaled gas compositions. The middle lobe and lingula, constrained by their isolated, segmental anatomy, have reduced collateral ventilation, which predisposes them to disease. Recently, attempts to improve the quality of life of patients with emphysema, by performing nonsurgical lung volume reduction via use of endobronchial valves, have led to mixed results, because the role of collateral ventilation in the success or failure of the procedure was not initially appreciated. This review describes the anatomical pathways of collateral ventilation, their physiology and relationship to disease states, their modulatory effects on gas exchange, treatment considerations, and their effect on diagnostic procedures.


  • Neuropathophysiology of Brain Injury

    by Nidia Quillinan, Paco S. Herson, Richard J. Traystman


  • Animal Models of Stroke: Translational Potential At Present and In 2050

    by Paco S Herson, Richard J Traystman

    Translation from basic science bench research in ischemic stroke to bedside treatment of patients suffering ischemic stroke remains a difficult challenge. Despite literally hundreds of compounds and interventions that provide benefit in experimental models of cerebral ischemia, efficacy in humans remains to be demonstrated. The reasons for failure to translate the extensive positive basic science findings to successful clinical trials have been the focus of discussion for years. Some attribute the failure to flaws in clinical trial design, others question the predictive value of current animal models and some question the quality of preclinical data. It is likely that a combination of all these shortcomings have ultimately led to the failure. The purpose of this review is to analyze the commonly used animal models used in the field today, provide a framework for understanding the current state of basic science research in the ischemic stroke field and discuss a path forward.


  • Introduction

    by Richard J. Traystman